A. Cid

发表

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors

J. Oldenburg, R. Ljung, E. Santagostino, 2017, Thrombosis and Haemostasis.

Factor VIII products and inhibitor development in severe hemophilia A.

R. Ljung, E. Santagostino, J. G. van der Bom, 2013, The New England journal of medicine.

Molecular analyses in hemophilia B families: identification of six new mutations in the factor IX gene.

A. Cid, J. Aznar, S. Haya, 2003, Haematologica.

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

R. Ljung, M. Carcao, A. Rafowicz, 2015, Haematologica.

Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.

A. Cid, J. de la Rubia, J. Martínez, 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Influence of Methylene Blue Photoinactivation Treatment on Coagulation Factors from Fresh Frozen Plasma, Cryoprecipitates and Cryosupernatants

J. Montoro, A. Cid, J. Aznar, 2000, Vox Sanguinis.

Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A

V. Jiménez‐Yuste, T. Lissitchkov, A. Cid, 2019, Thrombosis and Haemostasis.

Diagnosis and management of von willebrand disease in Spain

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018 .

Inhibitors in haemophilia A: current management and open issues

A. Cid, J. Aznar, A. Moret, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment

J. Montoro, A. Cid, J. Aznar, 2001, Haemophilia : the official journal of the World Federation of Hemophilia.

One‐stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

A. Cid, J. Aznar, A. Moret, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation

A. Cid, J. Aznar, N. Cabrera, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real‐world report from a single centre, mixed retrospective‐prospective long‐term study

C. Solano, D. Hervás, A. Cid, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism

J. Griffin, A. Gruber, L. Ramón, 2018, Thrombosis and Haemostasis.

Effective prophylaxis with rFVIIa in young haemophiliacs with inhibitors using a schedule similar to FVIII prophylaxis in non-inhibitor patients *

V. Jiménez‐Yuste, A. Cid, C. Altisent, 2013 .

Response to Plasma Exchange and Steroids as Combined Therapy for Patients with Thrombotic Thrombocytopenic Purpura

M. Sanz, A. Cid, J. de la Rubia, 1999, Acta Haematologica.

Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management

J. Cervera, A. Cid, A. Moret, 2020, Journal of Thrombosis and Thrombolysis.

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018, PloS one.

Founder haplotype associated with the factor VIII Asp1241Glu polymorphism in a cohort of mild hemophilia A patients

F. Martínez, A. Cid, J. Aznar, 2008, Journal of thrombosis and haemostasis : JTH.

Ultrasonography in the monitoring of management of haemarthrosis

S. Pérez-Alenda, A. Cid, J. Aznar, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

When Should we Switch from On‐Demand to Prophylaxis Regimen?

A. Cid, J. Aznar, A. Moret, 2011 .

Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol)

A. Cid, J. Aznar, S. Haya, 2008, Haemophilia : the official journal of the World Federation of Hemophilia.

Development of a new disease‐specific quality‐of‐life questionnaire to adults living with haemophilia

E. Remor, P. Arranz, A. Cid, 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery

A. Sytkowski, G. Castaman, O. Stasyshyn, 2018, Journal of thrombosis and haemostasis : JTH.

Molecular and clinical profile of von Willebrand disease in Spain (PCM–EVW–ES): Proposal for a new diagnostic paradigm

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2015, Thrombosis and Haemostasis.

Orthoses in haemophilia

A. Cid, J. Aznar, S. Haya, 2002, Haemophilia.

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders

P. Nurden, P. Noris, R. Favier, 2017, Haematologica.

A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment.

J. Montoro, A. Cid, J. Aznar, 2001 .

Cross‐sectional comparative study of pharmacokinetics and efficacy between sucrose‐formulated recombinant factor VIII (Kogenate®) and BAY 81‐8973 (Kovaltry®) in patients with severe or moderate haemophilia A in prophylaxis

S. Pérez-Alenda, J. Poveda, A. Cid, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study

P. Nurden, P. Noris, R. Favier, 2019, Haematologica.

Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings

V. Jiménez‐Yuste, J. Korth-Bradley, A. Cid, 2015, Thrombosis and Haemostasis.

Rehabilitation of Patients with Haemophilia and Inhibitors

A. Cid, J. Aznar, S. Haya, 2008 .

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2017, Haematologica.

Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor‐induced platelet agglutination method

F. España, A. Cid, J. Aznar, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

First application of MLPA method in severe von Willebrand disease. Confirmation of a new large VWF gene deletion and identification of heterozygous carriers

A. Cid, J. Aznar, A. Moret, 2011, British journal of haematology.

Von Willebrand's disease: a novel mutation, P1824H and the incidence of R1205H defect among families with dominant quantitative von Willebrand factor deficiency.

A. Cid, J. Aznar, N. Cabrera, 2006, Haematologica.

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2020, Thrombosis and Haemostasis.

Influence of Methylene Blue Photoinactivation Treatment on Coagulation Factors from Fresh Frozen Plasma, Cryoprecipitates and Cryosupernatants

J. Montoro, A. Cid, J. Aznar, 2000, Vox Sanguinis.

Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study

V. Vicente, A. Cid, M. Lozano, 2014, Orphanet Journal of Rare Diseases.

Allogeneic hematopoietic cell transplantation in an adult patient with Glanzmann thrombasthenia

M. Sanz, V. Vicente, J. Sanz, 2017, Clinical case reports.

Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.

David S. Paul, J. Hernández-Rivas, S. Watson, 2016, Blood.

A simplified assay for the quantification of circulating activated protein C.

L. Ramón, F. España, J. Corral, 2016, Clinica chimica acta; international journal of clinical chemistry.

Carboplatin plus cytarabine in the treatment of high-risk acute myeloblastic leukemia

M. Sanz, A. Cid, G. Sanz, 1999, Leukemia.

Large deletion in the Factor VIII gene (F8) involving segmental duplications in int22h shows no haematological phenotype in female carriers, but may be embryonic lethal in males

M. Roselló, C. Orellana, F. Martínez, 2012, British journal of haematology.

Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC

P. Noris, A. Tosetto, P. Fontana, 2019, Journal of thrombosis and haemostasis : JTH.

Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

J. González-Porras, F. España, A. Vayá, 2019, Thrombosis and Haemostasis.

Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders

P. Nurden, P. Noris, R. Favier, 2015, British journal of haematology.

Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen.

J. Cervera, A. Cid, A. Moret, 2019, Thrombosis research.

The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology

P. Noris, M. Alessi, P. Fontana, 2021, Journal of thrombosis and haemostasis : JTH.

Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency

J. Cervera, A. Cid, A. Moret, 2019, Journal of Thrombosis and Thrombolysis.

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

V. Jiménez‐Yuste, J. Mateo, J. Batlle, 2018, Haematologica.

Severe and moderate hemophilia A: identification of 38 new genetic alterations

A. Cid, J. Aznar, N. Cabrera, 2008, Haematologica.

Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC

P. Noris, A. Tosetto, P. Fontana, 2019, Journal of thrombosis and haemostasis : JTH.

Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease

A. Cid, N. Cabrera, S. Haya, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Less common hemorrhagic coagulopathies in women.

A. Cid, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study

C. Hermans, K. Khair, C. Négrier, 2023, Therapeutic advances in hematology.

Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A.

S. Pérez-Alenda, J. Poveda, A. Cid, 2019, Thrombosis research.